Sean M. Devlin
0000-0002-6801-720X
Publication & Citation Trends
Publications
0 total
Daratumumab versus Lenalidomide Maintenance Therapy in Newly Diagnosed Multiple Myeloma – Quality of Life and Efficacy Results from a Randomized Investigator-initiated Trial
Cited by 0
Semantic Scholar
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma
Cited by 5
Semantic Scholar
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
Cited by 6
Semantic Scholar
Patterns and safety of glucocorticosteroid use following CD19 CAR‐T therapy for large B‐cell lymphoma
Cited by 0
Semantic Scholar
Stem Cell Autograft Minimal Residual Disease Negativity Predicts Improved Outcomes After Autologous Stem Cell Transplant for Multiple Myeloma
Cited by 0
Semantic Scholar
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma
Cited by 3
Semantic Scholar
Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma : a multi-center propensity score-matched analysis.
Cited by 0
Semantic Scholar
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact
Cited by 0
Semantic Scholar
Research Topics
Hematopoietic Stem Cell Transplantation
(211)
Acute Myeloid Leukemia Research
(162)
Multiple Myeloma Research and Treatments
(105)
CAR-T cell therapy research
(104)
Acute Lymphoblastic Leukemia research
(87)
Affiliations
Memorial Sloan Kettering Cancer Center
United States Fish and Wildlife Service
University of Washington
Cornell University
Kettering University